These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8875976)

  • 1. p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage.
    Knippschild U; Milne D; Campbell L; Meek D
    Oncogene; 1996 Oct; 13(7):1387-93. PubMed ID: 8875976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
    Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
    Milne DM; Palmer RH; Campbell DG; Meek DW
    Oncogene; 1992 Jul; 7(7):1361-9. PubMed ID: 1620549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of JNK1 with p21waf1 and p53: modulation of JNK1 activity.
    Xue Y; Ramaswamy NT; Hong X; Pelling JC
    Mol Carcinog; 2003 Jan; 36(1):38-44. PubMed ID: 12503078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification.
    Jardine LJ; Milne DM; Dumaz N; Meek DW
    Oncogene; 1999 Dec; 18(52):7602-7. PubMed ID: 10602521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
    Hansen S; Lane DP; Midgley CA
    J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conformational change of a murine temperature-sensitive p53 protein is independent of a change in phosphorylation status.
    Picksley SM; Meek DW; Lane DP
    Oncogene; 1992 Aug; 7(8):1649-51. PubMed ID: 1630825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hyperthermia on p53 protein expression and activity.
    Guan J; Stavridi E; Leeper DB; Iliakis G
    J Cell Physiol; 2002 Mar; 190(3):365-74. PubMed ID: 11857452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
    Hu MC; Qiu WR; Wang YP
    Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 associates with trk tyrosine kinase.
    Montano X
    Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells.
    Abraham J; Spaner D; Benchimol S
    Oncogene; 1999 Feb; 18(8):1521-7. PubMed ID: 10102621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage.
    Dohoney KM; Guillerm C; Whiteford C; Elbi C; Lambert PF; Hager GL; Brady JN
    Oncogene; 2004 Jan; 23(1):49-57. PubMed ID: 14712210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage.
    Jimenez GS; Bryntesson F; Torres-Arzayus MI; Priestley A; Beeche M; Saito S; Sakaguchi K; Appella E; Jeggo PA; Taccioli GE; Wahl GM; Hubank M
    Nature; 1999 Jul; 400(6739):81-3. PubMed ID: 10403253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53.
    Turenne GA; Paul P; Laflair L; Price BD
    Oncogene; 2001 Aug; 20(37):5100-10. PubMed ID: 11526498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.
    Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J
    Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
    Satyamoorthy K; Chehab NH; Waterman MJ; Lien MC; El-Deiry WS; Herlyn M; Halazonetis TD
    Cell Growth Differ; 2000 Sep; 11(9):467-74. PubMed ID: 11007451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
    Li H; Cao Y; Berndt MC; Funder JW; Liu JP
    Oncogene; 1999 Nov; 18(48):6785-94. PubMed ID: 10597287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase activity associated with immunopurified p53 protein.
    Kraiss S; Barnekow A; Montenarh M
    Oncogene; 1990 Jun; 5(6):845-55. PubMed ID: 2141685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.